On October 14, 2026, Prolific Machines, a biotechnology company advancing biologics development and manufacturing through integrated optogenetics-enabled solutions, announced the initial closing of its $50 million Series B2 financing led by Atoms & Bits and Nant Capital. Wilson Sonsini Goodrich & Rosati advised Prolific Machines on patent and trademark matters related to the transaction.

Prolific Machines will use the funding to scale its optogenetics platform for biomanufacturing, grow its team, expand programs with pharmaceutical and biotechnology partners, and support early work toward tissue and organ fabrication.

The Wilson Sonsini team that advised Prolific Machines on patent and trademark matters related to the transaction includes:

Patents and Innovations
Ali Alemozafar
Seth Lee
Inyoung Choi

Trademark and Advertising
Aaron Hendelman
Chloe Delehanty

For more information, please see Prolific Machines’ news release.